Anthony Khawaja

Professor Anthony Khawaja is a globally recognized ophthalmology expert holding a Professorship at UCL Institute of Ophthalmology and serving as Honorary Consultant Ophthalmic Surgeon at Moorfields Eye Hospital. His dual academic-clinical roles span University College London, University of Cambridge, and King’s College London, with leadership positions across European ophthalmology consortia. Voted among the top 10 glaucoma specialists globally in 2025, he bridges cutting-edge research with patient care.

His educational foundation includes:

• MA (Cantab) from University of Cambridge
• MB BS from University College London
• Masters in Epidemiology (Nick Day Prize) from Cambridge
• PhD in Epidemiology from Cambridge
• Glaucoma Fellowship at Moorfields Eye Hospital
• Berkeley Fellowship at Harvard Medical School

Research focuses on glaucoma genetics, risk prediction modeling, and real-world treatment outcomes. His landmark 2018 Nature Genetics study revolutionized understanding of glaucoma's genetic architecture. Current work integrates genomic data with clinical records through UK-wide consortia to develop precision medicine approaches, emphasizing modifiable risk factors and surgical innovation.

His scientific impact is reflected in numerous awards:

• Cambridge Nick Day Prize & Royal College Foulds Trophy
• UKRI Future Leaders Fellowship & Lister Institute Prize
• Moorfields Research Medal (2016) & UCL Excellence Award (2018)
• Top 10 global glaucoma specialist ranking (2025)

Professor Khawaja directs major funded initiatives including the UK Glaucoma Genetics Consortium and Real-World Data Consortium, mentoring through the European Leadership Development Programme. His clinical guidance shapes national medication protocols (Roclanda) and European surgical standards (PreserFlo Microshunt), with research directly impacting patient care pathways across multiple healthcare systems.